HETERO HEALTHCARE Ltd feels proud to distribute and market its second drug to fight against COVID-19 called FAVIVIR under the license from Gilead Sciences. The DCGI has granted accelerated approval of FAVIVIR to meet the urgent medical need.

Hetero’s group company ‘Hetero Healthcare Limited’ is all set to supply 20,000 vials of Covifor(Remdesivir) across the country.